The Applied Process Company (APC), a process development, design and innovation company, announced the appointment of David Downey and Eoin McManus to its executive team.
These appointments reflect the significant and ongoing growth of APC’s business, with a doubling of headcount to 120 in the last two years.
Downey was most recently with Almac Group, as VP Commercial Operations, within the Drug Product business unit and brings more than twenty years of experience in business development, marketing and client management with a proven track record of building and developing successful outsource organisations.
McManus was most recently with Eli Lilly and Company, as Business Unit Leader, Kinsale Operations, leading its Engineering function, a company where he spent twenty-six years, with a proven track record in leading R&D, technical transfer, manufacturing and engineering organisations. He has championed the implementation of novel technologies such as continuous processing within the company.
Based at APC headquarters in Dublin, Ireland, Downey and McManus will report to Dr Mark Barrett, APC’s CEO.
Barrett said: “We are delighted to welcome David and Eoin to APC during this very exciting period in our company history. Both are excellent additions to our management team and join at a time when we are seeing unprecedented demand for our innovative capabilities and services accelerating breakthrough innovations in cell therapies, personalised oncology therapies and viral vector technologies for many of our client partners.”
“I look forward to David’s leadership of our commercial teams, meeting the increased needs of our clients along with recognising and communicating APC’s unique value proposition to the market. In parallel, Eoin will lead our Technical and Operational teams providing a unique environment for best in class scientific output that can materially benefit our client partners and the patients they serve.”
Downey started his career in Quality Assurance for Scherer DDS (now part of Catalent) in 1994 before moving to Quintiles Limited as Packaging Manager, then Director of Project Management, for its Clinical Trial packaging services.
Following that Downey relocated to Italy in 2002 working for Patheon Italia as Business Manager, for its Monza Operations. In the following five years he progressed to European Director of Business Management managing the client interface and commercial Technology Transfer teams. Downey then joined Almac Group in 2008.
McManus started his career in Engineering for Eli Lilly in 1991 before progressing to Operations in 1998 as Team Leader managing two new production areas. In 2004, he led Maintenance and then Process Engineering organisations with a focus on new technologies and technical transfers.
Following that in 2011, McManus relocated to the USA to lead a late stage R&D group having been promoted to Director for Technology Design and Development within Chemical Process R&D team at Eli Lilly. In 2013, he returned to Ireland as Business Unit Leader – Small Molecule Operations before moving to lead the Engineering function in 2017.
